Daclizumab induction in liver transplant recipients

Transplant Proc. 2001 Feb-Mar;33(1-2):1527. doi: 10.1016/s0041-1345(00)02583-5.
No abstract available

MeSH terms

  • Adult
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Daclizumab
  • Drug Administration Schedule
  • Graft Rejection / prevention & control*
  • Humans
  • Immunoglobulin G / administration & dosage*
  • Immunosuppressive Agents / administration & dosage*
  • Kidney Diseases / chemically induced
  • Kidney Diseases / prevention & control*
  • Liver Transplantation / immunology*
  • Middle Aged
  • Postoperative Complications / chemically induced
  • Postoperative Complications / prevention & control*
  • Prospective Studies
  • Tacrolimus / administration & dosage

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Daclizumab
  • Tacrolimus